SynthesisMalaria journal2026
Kidney and endothelial injury biomarkers as predictors of complications and mortality in patients with malaria: a systematic review.
Synthesis in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria-associated acute kidney injury (AKI) is a severe complication strongly associated with increased mortality. Early identification of high-risk patients remains difficult, as serum creatinine is a late marker of renal dysfunction. Renal and endothelial injury biomarkers may improve early detection and prognostic stratification.
methodsA systematic review was conducted according to PRISMA 2020 guidelines and prospectively registered in PROSPERO (CRD42025642952). A systematic search was performed in PubMed, Scopus, and Web of Science. The search strategy combined the terms ("kidney" AND "biomarkers" AND "malaria"). Included studies were evaluated using the Newcastle-Ottawa Scale (NOS) and the Methodological Index for Non-Randomized Studies (MINORS).
resultsThe combined evaluation of renal and endothelial biomarkers, together with clinical and laboratory parameters, allows improved characterization of AKI in malaria and supports risk stratification. Elevated biomarker levels were consistently associated with increased risk of renal complications and adverse outcomes.
conclusionRenal and endothelial biomarkers may represent promising tools for early detection and monitoring of malaria-associated AKI, with potential to improve risk stratification and clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.